mat2203
Generic: oral amphotericin B·Code: MAT2203
mat2203: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Matinas BioPharma Holdings, Inc. (MTNB) | Phase 3 |
Get deeper analysis on mat2203
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis